MedTrace Logo

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

NCT00131495 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 814

Last updated 2013-04-17

No results posted yet for this study

Summary

This study is designed to evaluate the efficacy and safety of 2 doses of the transdermal testosterone patch in naturally or surgically menopausal women with low libido who are not receiving systemic estrogen or estrogen progestin therapy.

Conditions

  • Hypoactive Sexual Desire Disorder

Interventions

DRUG

Testosterone (transdermal patches)

Testosterone patch (300mcg/day, changed twice a week for one year

DRUG

Placebo patch

placebo patch changed twice a week for one year

Sponsors & Collaborators

  • Warner Chilcott

    lead INDUSTRY

Principal Investigators

  • Sue Davis, MD · Monash Medical School, The Alfred Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-02-28
Completion
2007-02-28

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131495 on ClinicalTrials.gov